Tetanus Vaccine
Immunity against tetanus impaired in adults with type 2 diabetes
Published in Vaccine Weekly, February 22nd, 2006
Researchers in Turkey report, "The aim of this study was to compare serum levels of tetanus antibody in diabetic patients over 50 years of age with those of age-and sex-matched non-diabetic controls."
Ali Tamer at Izzet Baysal Medical School and collaborators explained, "The study population consisted of 115 type 2 diabetic patients and 115 age- and sex-matched nondiabetic patients. Serum levels of tetanus IgG were measured by a commercial ELISA kit, and levels over 0.1 IU/mL were considered protective."
"Mean serum levels of tetanus antibody in the diabetic and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-02-22)
More Articles from Vaccine Weekly
- Avian Influenza Vaccine
Virus-like particles of H9N2 influenza virus induce protection - Dendritic Cell Vaccine
Fas ligand induces cell-autonomous IL-23 production in dendritic cells - Diphtheria-Pertussis-Tetanus Vaccine
Modified vaccine reduces injection site reactions to DTaP vaccine - Measles-Mumps-Rubella Vaccine
New MMR vaccine is better tolerated than licensed vaccine in children - Pseudorabies Vaccine
Vaccination can eradicate pseudorabies in the Netherlands - Allergy & Immunology
Dendritic cells incubated with irradiated tumor cells enhance IFN-gamma and IL-4 production - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
